{
    "clinical_study": {
        "@rank": "156302", 
        "arm_group": {
            "arm_group_label": "Diagnostic (methylprednisolone and FDG PET/CT scan)", 
            "arm_group_type": "Experimental", 
            "description": "Within 1-14 days of undergoing standard FDG PET/CT scan, patients receive methylprednisolone IV and then undergo a second FDG PET/CT scan."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether giving an anti-inflammatory medication\n      (corticosteroid) prior to a positron emission tomography scan (PET) scan may reduce or\n      eliminate false findings related to inflammation"
        }, 
        "brief_title": "Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer", 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": "Lung Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To assess whether premedication with a corticosteroid may reduce false positive findings\n      on fluorodeoxyglucose (fludeoxyglucose F 18 [FDG[) PET/computed tomography (CT) scans in\n      lung cancer patients, by reducing radiotracer uptake in thoracic lymph nodes related to\n      inflammation.\n\n      OUTLINE:\n\n      Within 1-14 days of undergoing standard FDG PET/CT scan, patients receive methylprednisolone\n      intravenously (IV) and then undergo a second FDG PET/CT scan.\n\n      After completion of study treatment, patients are followed up for 2 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient undergoing initial staging of biopsy proven lung cancer (all cancer stages\n             included)\n\n          -  Undergone clinical FDG PET/CT scan within 14 days of enrollment\n\n        Exclusion Criteria:\n\n          -  Prisoners\n\n          -  Diabetic patients (on insulin, on oral hypoglycemic, or fasting glucose > 180 mg/dl)\n\n          -  Serious infection within 14 days of enrollment\n\n          -  Known hypersensitivity to methylprednisolone\n\n          -  Viral skin lesions\n\n          -  Immunocompromised ANC(absolute neutrophil count < 1000/microliter)\n\n          -  Pregnant/nursing\n\n          -  History of tuberculosis or systemic fungal disease\n\n          -  History of steroid psychosis\n\n          -  Current peptic ulcer disease or diverticulitis\n\n          -  Corticosteroid use within 14 days of enrollment (including inhaled steroids)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789892", 
            "org_study_id": "OSU-10012", 
            "secondary_id": "NCI-2012-00530"
        }, 
        "intervention": [
            {
                "arm_group_label": "Diagnostic (methylprednisolone and FDG PET/CT scan)", 
                "description": "Given IV", 
                "intervention_name": "methylprednisolone", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Depo-Medrol", 
                    "Medrol", 
                    "MePRDL", 
                    "Solu-Medrol", 
                    "Wyacort"
                ]
            }, 
            {
                "arm_group_label": "Diagnostic (methylprednisolone and FDG PET/CT scan)", 
                "description": "Undergo FDG PET/CT scan", 
                "intervention_name": "fludeoxyglucose F 18", 
                "intervention_type": "Radiation", 
                "other_name": [
                    "18FDG", 
                    "FDG"
                ]
            }, 
            {
                "arm_group_label": "Diagnostic (methylprednisolone and FDG PET/CT scan)", 
                "description": "Undergo FDG PET/CT scan", 
                "intervention_name": "positron emission tomography", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "FDG-PET", 
                    "PET", 
                    "PET scan", 
                    "tomography, emission computed"
                ]
            }, 
            {
                "arm_group_label": "Diagnostic (methylprednisolone and FDG PET/CT scan)", 
                "description": "Undergo FDG PET/CT scan", 
                "intervention_name": "computed tomography", 
                "intervention_type": "Procedure", 
                "other_name": "tomography, computed"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 8, 2013", 
        "link": {
            "description": "Jamesline", 
            "url": "http://cancer.osu.edu"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "FDG PET/CT: Reducing False Positive Mediastinal Uptake by Premedicating With Methylprednisolone", 
        "overall_official": {
            "affiliation": "Ohio State University Comprehensive Cancer Center", 
            "last_name": "David Barker, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The SUV on the first and second PET scans will be recorded and summarized on a receiver operating characteristic (ROC) curve. We will explore the ROC curve for percent change in SUV or uptake ratio from the first to the second scan. We will explore thresholds for SUV and uptake values on the ROC curve by determining the values of acceptable combinations of true positive fractions (TPF) and false positive fractions (FPFs). We will use regression methods to adjust for possible confounding patient demographics, disease severity and disease history.", 
            "measure": "Continuous standardized uptake values (SUV)", 
            "safety_issue": "No", 
            "time_frame": "Within 1-14 days of first scan"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789892"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University Comprehensive Cancer Center", 
            "investigator_full_name": "David Barker", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ohio State University Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ohio State University Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2013", 
        "why_stopped": "no patient accrual"
    }
}